These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3953203)

  • 1. Prognostic value of nuclear DNA content in follicular thyroid tumours.
    Bäckdahl M; Auer G; Forsslund G; Granberg PO; Hamberger B; Lundell G; Löwhagen T; Zetterberg A
    Acta Chir Scand; 1986 Jan; 152():1-7. PubMed ID: 3953203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear DNA content and prognosis in Hürthle cell tumours of the thyroid gland.
    Wallin G; Bäckdahl M; Lundell G; Auer G; Löwhagen T
    Acta Chir Scand; 1988 Sep; 154(9):501-4. PubMed ID: 3201861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical meaning of DNA content in the long term behaviour of follicular thyroid tumours: a 12-year follow up.
    Lukács GL; Balázs G; Zs-Nagy I; Mikó T
    Eur J Surg; 1994 Aug; 160(8):417-23. PubMed ID: 7811827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nuclear DNA content of thyroid adenocarcinoma].
    Yoshida A
    Nihon Geka Gakkai Zasshi; 1984 Oct; 85(10):1261-73. PubMed ID: 6503946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear DNA measurements in follicular thyroid adenomas.
    Bäckdahl M; Wallin G; Askensten U; Auer G; Grimelius L; Löwhagen T
    Eur J Surg Oncol; 1989 Apr; 15(2):125-9. PubMed ID: 2703057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurement of cellular DNA content in thyroid tumors by the flow cytometer].
    Motomura Y
    Nihon Geka Gakkai Zasshi; 1988 Jul; 89(7):1066-74. PubMed ID: 3221827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA cytophotometry of oxyphilic thyroid tumors].
    Pilch H; Back W; Winter J
    Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis between follicular adenoma and follicular carcinoma of the thyroid by nuclear DNA determination.
    Sprenger E; Löwhagen T; Vogt-Schaden M
    Acta Cytol; 1977; 21(4):528-30. PubMed ID: 269603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of nuclear DNA content in primary and metastatic papillary thyroid carcinoma.
    Bäckdahl M; Cohn K; Auer G; Forsslund G; Granberg PO; Lundell G; Löwhagen T; Willems JS; Zetterberg A
    Cancer Res; 1985 Jun; 45(6):2890-4. PubMed ID: 3986815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study.
    Wallin G; Bäckdahl M; Tallroth-Ekman E; Lundell G; Auer G; Löwhagen T
    Eur J Surg Oncol; 1989 Feb; 15(1):43-8. PubMed ID: 2465188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of DNA content in carcinoma of the rectum and rectosigmoid.
    Enblad P; Glimelius B; Bengtsson A; Pontén J; Påhlman L
    Acta Chir Scand; 1987; 153(7-8):453-8. PubMed ID: 3673455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nuclear DNA pattern of thyroid tumor].
    Tanaka H
    Nihon Jibiinkoka Gakkai Kaiho; 1992 Aug; 95(8):1239-46. PubMed ID: 1403317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
    Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
    Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic significance of nuclear DNA content in highly malignant thyroid tumors].
    Lukács G; Balázs G; Zs-Nagy I; Juhász F
    Wien Klin Wochenschr; 1990 Apr; 102(9):253-6. PubMed ID: 2375112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of blood vessel invasion by cells of thyroid follicular carcinoma using image processing combined with immunohistochemistry].
    Zhu QY
    Zhonghua Yi Xue Za Zhi; 1989 Oct; 69(10):573-5, 40. PubMed ID: 2620265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image cytometric DNA analysis of adrenocortical neoplasms as a prognostic parameter: a clinico-pathologic study of 13 patients.
    Lü X; Stallmach T; Gebbers JO
    Anal Cell Pathol; 1996 Oct; 12(1):1-11. PubMed ID: 8933905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the nucleolar organizer regions (NORs) in the thyroid follicular tumours. Comparison of the cytological and histopathological examinations.
    Musiatowicz B; Dziecioł J; Augustynowicz A; Miller-Famulska D; Sulik M; Famulski W; Chabowski A; Jabłońska E; Andrzejewicz A; Mielech W; Guzińska-Ostymowicz K
    Rocz Akad Med Bialymst; 1998; 43():186-93. PubMed ID: 9972054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.